These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6271553)

  • 21. Defective catabolism of low-density lipoprotein by fibroblasts from patients with I-cell disease.
    Williams JC; Weinstein DB; Miller AL; Steinberg D
    Biochem J; 1982 Jan; 202(1):183-90. PubMed ID: 7082306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences.
    Bradley WA; Gilliam EB; Gotto AM; Gianturco SH
    Biochem Biophys Res Commun; 1982 Dec; 109(4):1360-7. PubMed ID: 6301435
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum cholesterol levels in patients with familial hypercholesterolemia confirmed by tissue culture.
    Keller C; Harders-Spengel K; Spengel F; Wieczorek A; Wolfram G; Zöllner N
    Atherosclerosis; 1981 Apr; 39(1):51-9. PubMed ID: 7247990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low density lipoprotein receptors in cultured skin fibroblasts from psoriasis patients.
    Leren TP; Maartmann-Moe K; Thune P; Berg K
    Clin Genet; 1984 Mar; 25(3):230-41. PubMed ID: 6323070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia.
    Goldstein JL; Kita T; Brown MS
    N Engl J Med; 1983 Aug; 309(5):288-96. PubMed ID: 6306464
    [No Abstract]   [Full Text] [Related]  

  • 26. Degradation by cultured fibroblasts and macrophages of unmodified and 1,2-cyclohexanedione-modified low-density lipoprotein from normal and homozygous familial hypercholesterolaemic subjects.
    Knight BL; Soutar AK
    Biochem J; 1982 Jan; 202(1):145-52. PubMed ID: 6282270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Watanabe heritable hyperlipidemic rabbit. Animal model for familial hypercholesterolemia.
    Havel RJ; Yamada N; Shames DM
    Arteriosclerosis; 1989; 9(1 Suppl):I33-8. PubMed ID: 2643428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HMG-CoA reductase : mechanism of reaction and physiological role (author's transl)].
    Tanzawa K
    Tanpakushitsu Kakusan Koso; 1981 May; 26(6):815-28. PubMed ID: 7031774
    [No Abstract]   [Full Text] [Related]  

  • 29. Mannose 6-phosphate receptor-mediated uptake of modified low density lipoprotein results in down regulation of hydroxymethylglutaryl-CoA reductase in normal and familial hypercholesterolemic fibroblasts.
    Murray GJ; Neville DM
    J Biol Chem; 1980 Dec; 255(24):11942-8. PubMed ID: 6254987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy.
    Goldstein JL; Brown MS
    Med Clin North Am; 1982 Mar; 66(2):335-62. PubMed ID: 6279983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake and cellular degradation of low-density lipoprotein.
    Thompson GR
    Nutr Metab; 1980; 24 Suppl 1():12-8. PubMed ID: 6256691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia.
    Bihain BE; Yen FT
    Biochemistry; 1992 May; 31(19):4628-36. PubMed ID: 1581314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired adrenal reserve in the Watanabe Heritable Hyperlipidemic rabbit: implications for LDL-receptor function in steroidogenesis.
    Hoeg JM; Loriaux L; Gregg RE; Green WR; Brewer HB
    Metabolism; 1985 Feb; 34(2):194-7. PubMed ID: 3969018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (I) - Contribution to the Elucidation of the Pathophysiology of Human Hypercholesterolemia and Coronary Heart Disease.
    Shiomi M
    J Atheroscler Thromb; 2020 Feb; 27(2):105-118. PubMed ID: 31748469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of the Kober Medal to Joseph L. Goldstein and Michael S. Brown.
    Foster DW; Wilson JD
    J Clin Invest; 2002 Dec; 110(12):S5-9. PubMed ID: 12506882
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro.
    Miyanohara A; Sharkey MF; Witztum JL; Steinberg D; Friedmann T
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6538-42. PubMed ID: 2842777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein receptors and genetic control of cholesterol metabolism in cultured human cells.
    Brown MS; Goldstein JL
    Naturwissenschaften; 1975 Aug; 62(8):385-9. PubMed ID: 172803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.
    Cianflone KM; Maslowska MH; Sniderman AD
    J Clin Invest; 1990 Mar; 85(3):722-30. PubMed ID: 2312723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difference in saturable binding of low density lipoprotein to liver membranes from normocholesterolemic subjects and patients with heterozygous familial hypercholesterolemia.
    Harders-Spengel K; Wood CB; Thompson GR; Myant NB; Soutar AK
    Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6355-9. PubMed ID: 6292899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The low-density-lipoprotein receptor pathway in familial hypercholesterolaemia: its role in pathogenesis and its response to therapy.
    Packard CJ; Shepherd J
    Biochem Soc Trans; 1983 Dec; 11(6):634-6. PubMed ID: 6321263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.